Protection Against Autoimmune Diabetes in Mixed Bone Marrow Chimeras: Mechanisms Involved

Journal of Immunology

Volumn 158, Issue 3, 1997, Pages 1453-1457

  Mathieu, Chantal ^a   Casteels, Kristina ^a   Bouillon, Roger ^a   Waer, Mark ^a,b  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ADOPTIVE TRANSFER; ANIMAL; ARTICLE; BONE MARROW TRANSPLANTATION; C57BL MOUSE; CHIMERA; IMMUNOLOGY; IMMUNOTHERAPY; INSULIN DEPENDENT DIABETES MELLITUS; MOUSE; NONOBESE DIABETIC MOUSE; SPLEEN;

ADOPTIVE TRANSFER; ANIMALS; BONE MARROW TRANSPLANTATION; CHIMERA; DIABETES MELLITUS, TYPE 1; IMMUNOTHERAPY; MICE; MICE, INBRED C57BL; MICE, INBRED NOD; SPLEEN;

EID: 0031066658     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Rossini, A. A., D. L. Greiner, H. P. Friedman, and J. P. Mordes. 1993. Immunopathogenesis of diabetes mellitus. Diabetes Rev. 1:43.
2. Marmont, A. M. 1992. Autoimmunity and allogeneic bone marrow transplantation. Bone Marrow Transplant. 9:1.
3. Leiter, E. H., and D. V. Serreze. 1991. Autoimmune diabetes in the nonobese diabetic mouse: suppression of immune defects by bone marrow transplantation and implications for therapy. Clin. Immunol. Immunopathol. 59:323.
4. 1 mouse bone marrow chimeras. Diabetologia 33:84.
5. LaFace, D. M., and A. B. Peck. 1989. Reciprocal allogeneic bone marrow transplantation between NOD mice and diabetes-nonsusceptible mice associated with transfer and prevention of autoimmune diabetes. Diabetes 38:894.
6. 1 mice. Diabetes 37:252.
7. Ikehara, S., H. Ohtsuki, R. A. Good, H. Asamoto, T. Nakamura, K. Sekita, E. Muso, Y. Tochino, T. Ida, H. Kuzuya, H. Imura, and Y. Hamashima. 1985. Prevention of type I diabetes in nonobese diabetic mice by allogeneic bone marrow transplantation. Proc. Natl Acad. Sci. USA 82:7743.
8. Chester, C. H., M. Sykes, and D. H. Sachs. 1989. Multiple mixed chimeras: reconstitution of lethally irradiated mice with syngeneic plus allogeneic bone marrow from multiple strains. Res. Immunol. 140:503.
9. Sharabi, Y., and D. H. Sachs. 1989. Mixed chimerism and permanent specific transplantation tolerance induced by a nonlethal preparative regimen. J. Exp. Med. 169:493.
10. Sykes, M., Y. Sharabi, and D. H. Sachs. 1988. Achieving alloengraftment without graft-versus-host disease: approaches using mixed allogeneic bone marrow transplantation. Bone Marrow Transplant. 3:379.
11. Sykes, M., and D. H. Sachs. 1988. Mixed allogeneic chimerism as an approach to transplantation tolerance. Immunol. Today 9:23.
12. Good, R. A. 1993. Mixed chimerism and immunologic tolerance. New Engl. J. Med. 328:801.
13. Starzl, T. E., A. J. Demetris, N. Murase, S. Ildstad, C. Ricordi, and M. Trucco. 1992. Cell migration, chimerism and graft acceptance. Lancet 339:1579.
14. Starzl, T. E., A. J. Demetris, M. Trucco, N. Murase, C. Ricordi, S. Ildstad, H. Ramos, S. Todo, A. Tzakis, J. J. Fung, M. Nalesnik, A. Zeevi, W. A. Rudert, and M. Kocova. 1993. Cell migration and chimerism after whole organ transplantation: the basis of graft acceptance. Hepatology 17:1127.
15. Murase, N., T. E. Starzl, M. Tanabe, A. Fujisaki, H. Miyasawa, Y. E. Qing, C. P. Delaney, J. J. Fung, and A. J. Demetris. 1995. Variable chimerism, graft versus host disease, and tolerance after different kinds of cell and whole organ transplantation from Lewis to Brown-Norway rats. Transplantation 60:158.
16. Delaney, C. P., N. Murase, M. Chen-Woan, J. J. Fung, T. E. Starzl, and A. J. Demetris. 1996. Allogeneic hematolymphoid microchimerism and prevention of autoimmune disease in the rat. J. Clin. Invest. 97:217.
17. Li, H., L. Kaufman, S. S. Boggs, P. C. Johnson, K. D. Patrene, and S. T. Ildstad. 1996. Mixed allogeneic chimerism induced by a sublethal approach prevents autoimmune diabetes and reverses insulitis in nonobese diabetic (NOD) mice. J. Immunol. 156:380.
18. Mathieu, C., M. Vandeputte, R. Bouillon, and M. Waer. 1993. Protection against autoimmune diabetes by induction of mixed bone marrow chimerism. Transplant. Proc. 25:1266.
19. 3 prevents insulitis in NOD mice. Diabetes 41: 1491.
20. Boitard, C., R. Yasunami, M. Dardenne, and J. F. Bach. 1989. T cell mediated inhibition of the transfer of autoimmune diabetes in NOD mice. J. Exp. Med. 169:1669.
21. Speiser, D. E., Y. Chvatchko, R. M. Zinkernagel, and H. R. MacDonald. 1990. Distinct fates of self-specific T cells developing in irradiation bone chimeras: clonal deletion, clonal anergy or in vitro responsiveness to self-Mls-1a controlled by hemopoietic cells in the thymus. J. Exp. Med. 172:1305.
22. Speiser, D. E., R. K. Lees, H. Hengartner, R. M. Zinkernagel, and H. R. MacDonald. 1989. Positive and negative selection of T cell receptor V beta domains controlled by distinct cell populations in the thymus. J. Exp. Med. 170:2165.
23. Fowlkes, B. J., and F. Ramsdell. 1993. T-cell tolerance. Curr. Opin. Immunol. 5:873.
24. Rapoport, M. J., A. Jaramillo, D. Zipris, A. H. Lazarus, D. V. Serreze, E. H. Leiter, P. Cyopick, J. S. Danska, and T. L. Delovitch. 1993. Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in non-obese diabetic mice. J. Exp. Med. 178:87.